Clinical Investigation of Efficacy of Third-line and Beyond Pemetrexed Treatment in Advanced Non-squamous Non-small Cell Lung Cancer

Clinical Investigation of Efficacy of Third-line and Beyond Pemetrexed Treatment in Advanced Non-squamous Non-small Cell Lung Cancer

Background and objective Pemetrexed in combination with platinum or a single-agent has been approved for the first- and second-line treatment of non-small cell lung cancer (NSCLC). However, the role of pemetrexed therapy in the third-line and beyond treatment of NSCLC has yet to be generally accepte...

Full description

Bibliographic Details
Main Authors: Fei YU, Xiaoqing LIU, Xiaoyan LI, Jianjie LI, Wanfeng GUO, Haifeng QIN, Hongjun GAO
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2012-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Pemetrexed
Lung neoplasms
Chemotherapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2012.02.10

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2012.02.10

Similar Items